This short video features six spotlights of Burke Neurological Institute faculty members who share their personal commitment and dedication to neurological science by answering the question "What do you love about coming to work everyday?".
The Burke-Blythedale team believes the first step toward discovering effective therapies for children with neurological injuries and impairments is to be able to track, measure and analyze both brain behavior and brain function with far greater accuracy and precision than the current status quo.
With great honor, Dr. Raj Ratan, executive director of Burke Neurological Institute, has been invited to serve as a member of the Neural Oxidative Metabolism and Death Study Section, Center for Scientific Review for the term beginning July 01, 2018 and ending June 30, 2024.
Ekso Bionics Holdings, Inc., today announced that it will be expanding the first company-sponsored randomized, controlled clinical trial, the WISE study, started at Burke Medical Research Institute to include TIRR Memorial Herman and Barrow Neurological Institute.
This Holiday Season and throughout 2018 when you shop on AmazonSmile a donation of 0.5% of the price of your eligible AmazonSmile purchases can be directed towards advancing research at Burke Medical Research Institute.
Cerebral palsy (CP), caused by damage to the brain during childhood development, is the most common pediatric neurological disorder affecting movement. Classically, CP was believed to be purely a problem of movement of hands, arm, or legs.